ergotamine will raise the level or outcome of finerenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Closely. Keep an eye on serum potassium through initiation and dosage adjustment of possibly finererone or weak CYP3A4 inhibitors. Alter finererone dosage as necessary.Headache, intermittent claudication,